Überbrückende Antikoagulation bei Patienten unter Vitamin-K-Antagonisten: Eine Bestandsaufnahme

S M Schellong; H Riess; M Spannagl; H Omran; M Schwarzbach; F Langer; W Gogarten; P Bramlage; R M Bauersachs

doi:10.1007/s00101-018-0463-0

Überbrückende Antikoagulation bei Patienten unter Vitamin-K-Antagonisten: Eine Bestandsaufnahme

Standard

Überbrückende Antikoagulation bei Patienten unter Vitamin-K-Antagonisten: Eine Bestandsaufnahme. / Schellong, S M; Riess, H; Spannagl, M; Omran, H; Schwarzbach, M; Langer, F; Gogarten, W; Bramlage, P; Bauersachs, R M.

In: ANAESTHESIST, Vol. 67, No. 8, 08.2018, p. 599-606.

Research output: SCORING: Contribution to journal › SCORING: Review article › Research

Harvard

Schellong, SM, Riess, H, Spannagl, M, Omran, H, Schwarzbach, M, Langer, F, Gogarten, W, Bramlage, P & Bauersachs, RM 2018, 'Überbrückende Antikoagulation bei Patienten unter Vitamin-K-Antagonisten: Eine Bestandsaufnahme', ANAESTHESIST, vol. 67, no. 8, pp. 599-606. https://doi.org/10.1007/s00101-018-0463-0

APA

Schellong, S. M., Riess, H., Spannagl, M., Omran, H., Schwarzbach, M., Langer, F., Gogarten, W., Bramlage, P., & Bauersachs, R. M. (2018). Überbrückende Antikoagulation bei Patienten unter Vitamin-K-Antagonisten: Eine Bestandsaufnahme. ANAESTHESIST, 67(8), 599-606. https://doi.org/10.1007/s00101-018-0463-0

Vancouver

Schellong SM, Riess H, Spannagl M, Omran H, Schwarzbach M, Langer F et al. Überbrückende Antikoagulation bei Patienten unter Vitamin-K-Antagonisten: Eine Bestandsaufnahme. ANAESTHESIST. 2018 Aug;67(8):599-606. https://doi.org/10.1007/s00101-018-0463-0

Bibtex

@article{88332490a1794e32b8f6f15915d69f1c,

title = "{\"U}berbr{\"u}ckende Antikoagulation bei Patienten unter Vitamin-K-Antagonisten: Eine Bestandsaufnahme",

abstract = "Approximately 30% of patients receiving oral anticoagulation using vitamin K antagonists (VKA) require surgery within 2 years. In this context, a clinical decision on the need and the mode of a peri-interventional bridging with heparin is needed. While a few years ago, bridging was almost considered a standard of care, recent study results triggered a discussion on which patients will need bridging at all. Revisiting the currently available recommendations and study results the conclusion can be drawn that the indications for bridging with heparin must nowadays be taken more narrowly and considering the individual patient risk of bleeding and thromboembolism. Bridging with heparin is only needed in patients with a very high risk of thromboembolism. This overview aims to give guidance for a risk-adapted peri-interventional approach to management of patients with a need for long-term anticoagulation using VKA.",

keywords = "English Abstract, Journal Article, Review",

author = "Schellong, {S M} and H Riess and M Spannagl and H Omran and M Schwarzbach and F Langer and W Gogarten and P Bramlage and Bauersachs, {R M}",

year = "2018",

month = aug,

doi = "10.1007/s00101-018-0463-0",

language = "Deutsch",

volume = "67",

pages = "599--606",

journal = "ANAESTHESIST",

issn = "0003-2417",

publisher = "Springer",

number = "8",

}

RIS

TY - JOUR

T1 - Überbrückende Antikoagulation bei Patienten unter Vitamin-K-Antagonisten: Eine Bestandsaufnahme

AU - Schellong, S M

AU - Riess, H

AU - Spannagl, M

AU - Omran, H

AU - Schwarzbach, M

AU - Langer, F

AU - Gogarten, W

AU - Bramlage, P

AU - Bauersachs, R M

PY - 2018/8

Y1 - 2018/8

N2 - Approximately 30% of patients receiving oral anticoagulation using vitamin K antagonists (VKA) require surgery within 2 years. In this context, a clinical decision on the need and the mode of a peri-interventional bridging with heparin is needed. While a few years ago, bridging was almost considered a standard of care, recent study results triggered a discussion on which patients will need bridging at all. Revisiting the currently available recommendations and study results the conclusion can be drawn that the indications for bridging with heparin must nowadays be taken more narrowly and considering the individual patient risk of bleeding and thromboembolism. Bridging with heparin is only needed in patients with a very high risk of thromboembolism. This overview aims to give guidance for a risk-adapted peri-interventional approach to management of patients with a need for long-term anticoagulation using VKA.

AB - Approximately 30% of patients receiving oral anticoagulation using vitamin K antagonists (VKA) require surgery within 2 years. In this context, a clinical decision on the need and the mode of a peri-interventional bridging with heparin is needed. While a few years ago, bridging was almost considered a standard of care, recent study results triggered a discussion on which patients will need bridging at all. Revisiting the currently available recommendations and study results the conclusion can be drawn that the indications for bridging with heparin must nowadays be taken more narrowly and considering the individual patient risk of bleeding and thromboembolism. Bridging with heparin is only needed in patients with a very high risk of thromboembolism. This overview aims to give guidance for a risk-adapted peri-interventional approach to management of patients with a need for long-term anticoagulation using VKA.

KW - English Abstract

KW - Journal Article

KW - Review

U2 - 10.1007/s00101-018-0463-0

DO - 10.1007/s00101-018-0463-0

M3 - SCORING: Review

C2 - 29926118

VL - 67

SP - 599

EP - 606

JO - ANAESTHESIST

JF - ANAESTHESIST

SN - 0003-2417

IS - 8

ER -